These 12 Best Stocks Under $5 Don’t Have Hefty Price Tags But Some Offer Hefty Rewards
Buying top stocks under $5 could be part of the successful strategy you’ve been waiting for. These stocks are very attractive because of their low investment amount. But, you must do your due diligence for the best ROI (Return On Investment). When you do your homework, the best stocks under $5 will help provide you the financial growth and prosperity you seek.
Best Stocks Under $5 To Buy In 2021
Cheap stocks are often overlooked by investors who are fearful of the high risk that comes with a lower share price. But when you do your research, you may find excellent low-priced stocks that will bring good returns. Here are 12 of the best stocks under $5 to buy right now.
1. Fortress Biotech
Stock Price: $4.23 (+$0.20)
Fortress Biotech, Inc. is an innovative biopharmaceutical company focused on identifying and developing high-potential drugs and development-stage drug prospects. Headquartered in New York City and founded in 2006. They develop and commercialize products both within the company and through partner companies.
They have over 25 programs in pre-clinical and clinical development across partner companies that span several large-market areas. Including rare diseases, oncology and gene therapy, which creates value for shareholders.
2. Genworth Financial
Stock Price $3.61 (+$0.15)
Making decisions about home health care services, adult daycare, or facility care options isn’t an easy task. Genworth has a partnership with CareScout to provide professionally trained care coordination advocates that work directly with your family. Company Headquarters is located in Richmond, VA and founded on October 23, 2003
Their homeownership programs help qualified borrowers buy a house with a low down payment and affordable monthly payments with mortgage insurance. There was some worry, but Genworth may have actually benefited from the pandemic.
Revenue for the fourth quarter was up 12% and grew similarly for the full year. Highlighted by how the pandemic seems to have increased the number of newly underwritten policies. Partly by a surge in first home purchases, which often require the purchase of mortgage insurance.
Stock Price $2.87 (+$0.06)
Otonomy is a biopharmaceutical company, that develops therapeutics for neurotology. Headquartered in California and founded in 2008. Hearing, balance and connection, are all easy to take for granted. But highly impactful when disrupted.
Disorders of the ear are often associated with feelings of frustration, decreased social interactions and depression. At Otonomy, the focus is on making new treatments a reality. For millions living with the debilitating, daily impact of these conditions.
4. Nokia Corp.
Stock Price $4.08 (+$0.06)
The Nokia Corporation is a telecommunication, information technology, and consumer electronics company. Founded in 1865 in Tampere, Finland.
With headquarters in Espoo, Finland, in the greater Helsinki metropolitan area. Earlier this month, the company announced a patent licensing deal with Samsung Electronics. This is by far Nokia’s biggest business.
The company is expected to post steady sales and earnings over the next couple of years as it rebuilds itself. Given the recovery backdrop at the same time, the 5G revolution is starting in earnest. Those outlooks may underestimate what’s coming for this telecom technology company.
Stock Price $3.74 (+$0.02)
MannKind was built with the guidance of legendary innovator and humanitarian Alfred E.Mann. Their team of passionate scientists, researchers and other professionals develop cutting-edge therapeutic products and technologies. That help people take control of their health.
With the development and commercialization of new therapeutic products and technologies. They give people the tools they need to thrive and prosper. Company Headquarters is located in Westlake Village, California, founded in February 1991.
Stock Price: $1.60 (+0.11)
CohBar, Inc. is a clinical-stage biotechnology company. They are highly engaged in research and development of mitochondria-based therapeutics (MBTs) for the treatment of chronic and age-related diseases. They were founded in 2007 and are headquartered in Menlo Park, CA.
Cohbar is a leader in exploring the mitochondrial genome for therapeutically relevant peptides. With the potential to be developed into transformative and commercially successful drugs. The company has discovered more than 100 mitochondrial-derived peptides (MDPs) and generated over 1,000 analogs.
7. BGC Partners
Stock Price: $4.42 (-0.06)
BGC Partners is an American global financial services company with headquarters in New York City. It was originally formed as part of the larger Cantor Fitzgerald organization. BGC Partners became its own entity in 2004.
BGC Partners Fenics GO was recently named Risk.net’s 2021 OTC (over-the-counter) trading platform of the year. Clients/users are added steadily to its suite of trading technologies.
Customers include many of the world’s largest banks, broker-dealers, investment banks, trading firms, hedge funds, governments, corporations, and investment firms.
8. Motus GI
Stock Price: $1.41 (+0.02)
Motus GI Holdings, Inc. is a highly engaged medical technology company, with subsidiaries in the U.S. and Israel. The Company’s flagship product is the Pure-Vu® System. A U.S. FDA-approved medical device designed to help facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure.
The device integrates with standard and slim colonoscopes to enable a quick yet safe cleansing during the procedure. While preserving established procedural workflow and techniques. Headquarters are in Fort Lauderdale, FL., founded in 2016.
9. BioDelivery Sciences International
Stock Price: $3.96 (+0.04)
BioDelivery Sciences International, Inc. headquartered in Raleigh, NC, is a rapidly growing specialty pharmaceutical company. Dedication to patients living with serious and complex chronic conditions is of the highest priority.
BDSI works to advance therapies designed to give individuals living with severe and debilitating chronic conditions, the opportunity to make the most of their lives.
Total company net revenue increased 40% vs prior year to reach an all-time high of $156.5 Million. Record levels of profitability with net income of $25.7 Million.
10. VOC Energy Trust
Stock Price: $3.31 (+0.02)
VOC founded in 2010, acquires and holds a term net profits interest. Of the net proceeds from the production and sale of the interests in oil and natural gas properties. In the states of Kansas and Texas. The company has an 80% term net profits interest of the net proceeds of the underlying properties.
VOC stock was forced to halt its dividend payments due to low oil prices in the second quarter of 2020. Now, with crude recovering, so too has VOC. Today the trust is providing shareholders with a whopping 9% dividend yield. The company is based out of Houston, Texas.
Stock Price: $2.48 (+$0.03)
Exicure, Inc. headquartered in Chicago, Illinois and founded in 2011. Is a clinical-stage biotechnology company. Which develops a new class of immunomodulatory and gene regulating drugs against validated targets.
The company’s proprietary spherical nucleic acid (SNA) architecture is designed to unlock the potential of therapeutic oligonucleotides. In a wide spectrum of cells and tissues. Exicure’s leading programs address inflammatory diseases, oncology and genetic disorders.
12. Entasis Therapeutics
Stock Price: $2.71 (-0.11)
Entasis Therapeutics headquartered in Waltham, MA, established in 2015. Was a spin-off from and with initial funding from AstraZeneca. Since receiving funding from AstraZeneca. ETTX has raised $81.9 million in gross proceeds from equity financings from several U.S. and European healthcare specialist investment firms.
Investing in these top stocks under $5 can help bring you the financial freedom you desire. However, as with all investment opportunities, do your due diligence before choosing the investment that appeals to you.
It’s an exciting time in the investment world! With the Pandemic seemingly on the decline. Things are beginning to look up again for some. Recovery is hopeful and on the rise.